not tagged
bms
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'bms', 'scienceatbms']
at #asco22, join us in hall d1 or tune in virtually for a post-hoc analysis from a phase 3 study evaluating neoadjuvant #immunotherapy + chemotherapy in patients with resectable #nsclc. #lcsm.
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: